Abstract

ObjectivesTo assess the value of cardiac MRI in comparison to echocardiography in consecutive patients with previously diagnosed and new suspected hypertrophic cardiomyopathy (HCM).MethodsAll MRI studies of patients with HCM or suspected disease performed at our centre within a 10-year time period were evaluated. Initial diagnoses (echocardiography-based) and final (MRI-based) diagnoses were compared in subgroups, and the discrepancies were recorded.ResultsA total of 1006 subjects with HCM or suspected HCM were identified (61% males, 39% females; median age, 49.1 years; interquartile range, 34.9–60.4). In 12 (2.2%) out of 550 patients with known HCM, MRI indicated a diagnosis other than HCM, including but not limited to the subaortic membrane (n = 1, 8.3%) or mild left ventricular hypertrophy (n = 5, 41.7%). Among all patients with suspected HCM (n = 456), MRI diagnosis was different from HCM in 5.3% (n = 24) of patients. In an additional 20.4% of patients (n = 93), no significant hypertrophy was present. In total, among patients with suspected HCM, MRI led to clear HCM diagnosis in 204 (44.7%) patients. Among patients with a history of uncontrolled hypertension suspected of having HCM, MRI aided in identifying cardiomyopathy in 47.9% of patients. This subgroup contained the largest proportion of patients with an ambiguous diagnosis, namely, 29.6% compared with 13.8% in the remaining groups of patients with suspected HCM (p = 0.0001).ConclusionsIn a small but important group of patients with ultrasound-based HCM, cardiac MRI can diagnose previously unknown conditions and/or refute suspected cardiomyopathy. The diagnostic yield of MRI when compared to echocardiography in patients suspected of having HCM is 44.7%.Key Points• Out of 550 patients previously diagnosed with echocardiography but without magnetic resonance imaging (MRI) as having hypertrophic cardiomyopathy (HCM), we diagnosed a different disease in 12 (2.2%) patients using MRI.• Among patients with suspected HCM based on echocardiography, MRI led to clear HCM diagnosis in 44.7% of patients.• In patients with a history of uncontrolled hypertension suspected, based on an echocardiogram, of having HCM, MRI aided in identifying cardiomyopathy in 47.9% of patients. This subgroup contained the largest proportion of patients with an ambiguous diagnosis.

Highlights

  • Cardiac magnetic resonance imaging (MRI) has revolutionised our understanding and management of various cardiovascular diseases

  • We hypothesised that cardiac MRI would be able to uncover previously unknown disease in patients with hypertrophic cardiomyopathy (HCM) established by echocardiography

  • All consecutive patients referred for MRI studies with an echocardiographybased diagnosis of HCM or suspected of having HCM based on echocardiogram were included

Read more

Summary

Introduction

Cardiac magnetic resonance imaging (MRI) has revolutionised our understanding and management of various cardiovascular diseases. Because of its excellent ability to non-invasively characterise tissue, cardiac MRI has emerged as useful in patients with cardiomyopathies, including patients with suspected or confirmed hypertrophic cardiomyopathy (HCM) [1,2,3]. MRI is useful in patients with poor acoustic windows and inadequate image quality of an ultrasound study and for the differential diagnosis of left ventricular hypertrophy (LVH), which can be caused by several conditions including HCM, Fabry disease or cardiac amyloidosis [3]. We hypothesised that cardiac MRI would be able to uncover previously unknown disease in patients with HCM established by echocardiography.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call